1. Home
  2. RNAZ vs CNF Comparison

RNAZ vs CNF Comparison

Compare RNAZ & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

CNF

CNFinance Holdings Limited each representing twenty (20)

SELL

Current Price

$2.18

Market Cap

31.9M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RNAZ
CNF
Founded
2016
1999
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
31.9M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
RNAZ
CNF
Price
$1.04
$2.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 19.2K
6.2K
Earning Date
11-16-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$1.37
52 Week High
$12.60
$6.49

Technical Indicators

Market Signals
Indicator
RNAZ
CNF
Relative Strength Index (RSI) 25.80 69.37
Support Level N/A $2.12
Resistance Level $1.93 $2.46
Average True Range (ATR) 0.16 0.15
MACD -0.02 0.03
Stochastic Oscillator 6.42 96.71

Price Performance

Historical Comparison
RNAZ
CNF

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.

Share on Social Networks: